Insight Pharmaceuticals Voluntarily Recalls Topical Anesthetic Spray, Cites Benzene Content




TARRYTOWN, N.Y. –– A pharmaceutical company has recalled one lot of a topical anesthetic spray product saying that a “recent review by our manufacturer and their third-party lab found that a sample from one lot of the product showed a low level of benzene came from the propellant that sprays the product out of the can.”

In a Dec. 22 company announcement, Insight Pharmaceuticals stressed that no other lots of its Americaine ® 20 percent Benzocaine Topical Anesthetic Spray “are in the scope of this recall and may continue to be used by consumers safely and as intended.”

The announcement …






UPCOMING CONFERENCES




HarrisMartin's New Jersey Asbestos Litigation Conference

March 01, 2024 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS



HarrisMartin's Ozempic MDL Conference: Updates from the Status Hearing

March 15, 2024 - Philadelphia, PA
Kimpton Hotel Monaco Philadelphia

MORE DETAILS